Personalized nanomedicine: a rapid, sensitive, and selective UV–vis spectrophotometry method for the quantification of nanostructured PEG-asparaginase activity in children’s plasma

References

• Lustosa de SousaDWde Almeida FerreiraFVCavalcante FélixFHde Oliveira LopesMVAcute lymphoblastic leukemia in children and adolescents: prognostic factors and analysis of survivalRev Bras Hematol Hemoter201537422322926190424
   PubMedGoogle Scholar
• KawediaJDRyttingMEAsparaginase in acute lymphoblastic leukemiaClin Lymphoma Myeloma Leuk201414SupplS14S1725486949
   PubMedGoogle Scholar
• AppelIMKazemierKMBoosJPharmacokinetic, pharmacodynamic and intracellular effects of PEG-asparaginase in newly diagnosed childhood acute lymphoblastic leukemia: results from a single agent window studyLeukemia20082291665167918580955
   PubMed Web of Science ®Google Scholar
• PanettaJCGajjarAHijiyaNComparison of native E. coli and PEG asparaginase pharmacokinetics and pharmacodynamics in pediatric acute lymphoblastic leukemiaClin Pharmacol Ther200986665165819741605
   PubMed Web of Science ®Google Scholar
• QiaoJQiLMuXChenYMonolith and coating enzymatic microreactors of L-asparaginase: kinetics study by MCE-LIF for potential application in acute lymphoblastic leukemia (ALL) treatmentAnalyst2011136102077208321461410
   PubMed Web of Science ®Google Scholar
• BaruchMBelotserkovskyIHertzogBBAn extracellular bacterial pathogen modulates host metabolism to regulate its own sensing and proliferationCell20141561–29710824439371
   PubMed Web of Science ®Google Scholar
• RizzariCZucchettiMConterVL-asparagine depletion and L-asparaginase activity in children with acute lymphoblastic leukemia receiving i.m. or i.v. Erwinia C. or E. coli L-asparaginase as first exposureAnn Oncol200011218919310761754
   PubMed Web of Science ®Google Scholar
• AvramisVIPanosyanEHPharmacokinetic/pharmacodynamic relationships of asparaginase formulations: the past, the present and recommendations for the futureClin Pharmacokinet200544436739315828851
   PubMed Web of Science ®Google Scholar
• AlbertsenBKSchrøderHJakobsenPMüllerH-JCarlsenNTSchmiegelowKMonitoring of Erwinia asparaginase therapy in childhood ALL in the Nordic countriesBr J Clin Pharmacol2015524433437
   Google Scholar
• HoDHBrownNSYenAClinical pharmacology of polyethylene glycol-L-asparaginaseDrug Metab Dispos19861433492872037
   PubMed Web of Science ®Google Scholar
• YeLGhYPanMDingMQGuoFAdverse effect of L-asparaginase during its treatment of childhood acute lymphoblastic leukemiaAnhui Med Pharm J201115365366
   Google Scholar
• DinndorfPAGootenbergJCohenMHKeeganPPazdurRFDA drug approval summary: pegaspargase (Oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL)Oncologist200712899199817766659
   PubMed Web of Science ®Google Scholar
• ChenFXCuiYQWuZLResearch on the pharmacokinetics and pharmacodynamics of L-asparaginase during its treatment of childhood acute lymphoblastic leukemiaZhonghua Xue Ye Xue Za Zhi200526210015921627
   PubMedGoogle Scholar
• BalcãoVMMateoCFernández-LafuenteRMalcataFXGuisánJMStructural and functional stabilization of L-asparaginase via multisub-unit immobilization onto highly activated supportsBiotechnol Prog200117353754211386876
   PubMed Web of Science ®Google Scholar
• StecherALde DeusPMPolikarpovIAbrahão-NetoJStability of L-asparaginase: an enzyme used in leukemia treatmentPharm Acta Helv19997411910748619
   PubMedGoogle Scholar
• AfkhamiANorooz-AslRMicelle-mediated extraction and spectrophotometric determination of ammonia in water samples utilizing indophenol dye formationJ Braz Chem Soc200819815461552
   Web of Science ®Google Scholar
• TagamiSMatsudaKAn enzymatic method for the kinetic measurement of L-asparaginase activity and L-asparagine with an ammonia gas-sensing electrodeChem Pharm Bull19903811531552186873
   PubMed Web of Science ®Google Scholar
• YaoHVancoillieJD’HondtMWynendaeleEBrackeNde SpiegeleerBAn analytical quality by design (aQbD) approach for a L-asparagi-nase activity methodJ Pharm Biomed Anal201611723223926378979
   PubMed Web of Science ®Google Scholar
• BoosJWerberGAhlkeEMonitoring of asparaginase activity and asparagine levels in children on different asparaginase preparationsEur J Cancer199632A9154415508911116
   PubMed Web of Science ®Google Scholar
• WerberGAhlkeENowak-GöttlUJürgensHVerspohlEJBoosJAsparaginase Activities In Vitro Are Highly Sensitive to Different Buffer ConditionsBerlin, HeidelbergSpringer1997
   Google Scholar
• LanversCVieira PinheiroJPHempelGWuerthweinGBoosJAnalytical validation of a microplate reader-based method for the therapeutic drug monitoring of L-asparaginase in human serumAnal Biochem2002309111712612381370
   PubMed Web of Science ®Google Scholar
• SilvermanLBSupkoJGStevensonKEIntravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemiaBlood201011571351135320007809
   PubMed Web of Science ®Google Scholar
• ArmstrongJKHempelGKolingSAntibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patientsCancer2007110110311117516438
   PubMed Web of Science ®Google Scholar
• VillaPCoradaMBartosekIL-asparaginase effects on inhibition of protein synthesis and lowering of the glutamine content in cultured rat hepatocytesToxicol Lett19863232352413535170
   PubMed Web of Science ®Google Scholar
• MillerHKSalserJSBalisMEAmino acid levels following L-asparagine amidohydrolase (EC.3.5.1.1) therapyCancer Res19692911835763976
   PubMed Web of Science ®Google Scholar
• OllenschlägerGRothELinkeschWJansenSSimmelAMödderBAsparaginase-induced derangements of glutamine metabolism: the pathogenetic basis for some drug-related side-effectsEur J Clin Invest19881855125163147904
   PubMed Web of Science ®Google Scholar
• FuchsBCBodeBPStressing out over survival: glutamine as an apoptotic modulatorJ Surg Res20061311264016154153
   PubMed Web of Science ®Google Scholar
• MüllerHJBeierRda PalmaJCPEG-asparaginase (Oncaspar) 2500 U/m(2) BSA in reinduction and relapse treatment in the ALL/NHL-BFM protocolsCancer Chemother Pharmacol200249214915411862429
   PubMed Web of Science ®Google Scholar